STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
The paper gives the data of current studies, which suggest the dual mechanism of action of strontium ranelate on bone remodeling in postmenopausal osteoporosis (OP): the drug made bone rearrangement balance shift toward a predominance of the processes of new bone formation. Long-term studies dealing...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2010-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/308 |